Featured Research

from universities, journals, and other organizations

Enlarged prostate: Study demonstrates immediate and long-term benefits of laser treatment

Date:
May 21, 2011
Source:
McGill University Health Centre
Summary:
New research demonstrates that holmium laser therapy is a safe and durable treatment option for benign prostatic hyperplasia -- an enlargement of the prostate that affects most men as they age.

New research presented at the Annual Meeting of the American Urology Association (AUA) in Washington, DC demonstrates that holmium laser therapy is a safe and durable treatment option for Benign Prostatic Hyperplasia (BPH) -- an enlargement of the prostate that affects most men as they age. The study, conducted by researchers from the McGill University Health Centre (MUHC), is the longest comprehensive assessment of this technology to date, and researchers suggest it may now safely be considered the new, size independent, gold standard for treatment of BPH.

Related Articles


A man's prostate naturally increases in size throughout life, but can occasionally reach a very large size placing pressure on the urethra and causing urination difficulties and bladder problems. A prostate of 40-60 grams is the average size for which corrective surgery is considered. Holmium laser therapy of the prostate, also known as Holmium Laser Enucleation of the Prostate (HoLEP) has been used since 1998 at the MUHC as an alternative treatment to surgery. This is particularly valuable for patients who have particularly large prostates and risk factors that render open surgery difficult.

"Treating small to moderate size prostates by regular Transurethral Resection of the prostate (TURP) -- a surgical technique that removes part of the prostate gland -- is still the chosen treatment for the majority of patients," explains Dr. Mostafa Elhilali, Stephen Jarislowsky Chair of Urology at McGill University, urologist at the MUHC and lead author of the new study. "However, the most challenging aspect about the use of minimally invasive techniques is the high rate of recurrence and the need for re-treatment over time."

The study, which looked at the durability of outcomes of HoLEP in nearly 1,000 patients over 10 years, demonstrated that complication rates are minimal and the need for further treatment, even up to a decade later, is less than 1 per cent, compared to 10-16 per cent with TURP. "Patients treated with HoLEP also have reduced pain and shorter hospital stays than those who undergo an open surgery," explains Dr. Elhilali. "They are often able to resume normal activities within a week and have few to no sexual side effects."

The researchers point out that HoLEP is more effective at adequately treating all sizes of prostatic enlargement, whereas other laser techniques, such as Green Light Laser, is effective on small to moderate size prostates, similar but not better than TURP and lacks the same long-term durability. Green Light Laser has been used at the MUHC since 2005. The results of a study comparing Green Light Laser in different sized prostates showed it to be less effective in treating larger prostates. This study was also presented at the AUA meeting May 18, 2011.


Story Source:

The above story is based on materials provided by McGill University Health Centre. Note: Materials may be edited for content and length.


Cite This Page:

McGill University Health Centre. "Enlarged prostate: Study demonstrates immediate and long-term benefits of laser treatment." ScienceDaily. ScienceDaily, 21 May 2011. <www.sciencedaily.com/releases/2011/05/110520122229.htm>.
McGill University Health Centre. (2011, May 21). Enlarged prostate: Study demonstrates immediate and long-term benefits of laser treatment. ScienceDaily. Retrieved November 29, 2014 from www.sciencedaily.com/releases/2011/05/110520122229.htm
McGill University Health Centre. "Enlarged prostate: Study demonstrates immediate and long-term benefits of laser treatment." ScienceDaily. www.sciencedaily.com/releases/2011/05/110520122229.htm (accessed November 29, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Saturday, November 29, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Rural India's Low-Cost Sanitary Pad Revolution

Rural India's Low-Cost Sanitary Pad Revolution

AFP (Nov. 28, 2014) One man hopes his invention -– a machine that produces cheap sanitary pads –- will help empower Indian women. Duration: 01:51 Video provided by AFP
Powered by NewsLook.com
Research on Bats Could Help Develop Drugs Against Ebola

Research on Bats Could Help Develop Drugs Against Ebola

AFP (Nov. 28, 2014) In Africa's only biosafety level 4 laboratory, scientists have been carrying out experiments on bats to understand how virus like Ebola are being transmitted, and how some of them resist to it. Duration: 01:18 Video provided by AFP
Powered by NewsLook.com
WHO Says Male Ebola Survivors Should Abstain From Sex

WHO Says Male Ebola Survivors Should Abstain From Sex

Newsy (Nov. 28, 2014) WHO cites four studies that say Ebola can still be detected in semen up to 82 days after the onset of symptoms. Video provided by Newsy
Powered by NewsLook.com
Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins